Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;104:e9040-e9041
doi: 10.1161/hc4301.101125
This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SoRelle, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by SoRelle, R.

(Circulation. 2001;104:e9040.)
© 2001 American Heart Association, Inc.

Cardiovascular News

Ruth SoRelle, MPH

Circulation Newswriter

Transfusing Elderly Heart Attack Patients

Blood transfusions can reduce short-term mortality among elderly heart attack patients whose admission hematocrit is <=30% and may even help those with a hematocrit as high as 33%, according to researchers from Brown University Medical School and Yale University School of Medicine (N Engl J Med. 2001;345:1230–1236).

The report in the October 25, 2001, issue of the New England Journal of Medicine was designed to answer the questions about whether transfusion could help elderly patients with myocardial infarction and at what level of anemia. In the study, researchers, who were led by Wen Chih Wu, MD, of the Division of Cardiovascular Diseases at Brown University Medical School in Providence, RI, evaluated the care of 78 974 Medicare patients in the Cooperative Cardiovascular Project who were categorized according to their admission hematocrit. They found that patients who had lower hematocrit values on admission had higher 30-day mortality rates. Blood transfusion reduced the 30-day mortality rates in patients with hematocrits as high as 33%. However, blood transfusion was associated with higher 30-day death rates in patients with admission hematocrits >=36.1%.

"Although our study indicates that there is an overall benefit of transfusion in patients with acute myocardial infarction and anemia, patients who received transfusion despite the fact that their hematocrit values on admission were >36% had a higher risk of death within 30 days than patients with similar hematocrit values who did not receive transfusions," the authors wrote. "Very few patients with hematocrit values in this category received transfusions, and . . . [Full Text of this Article]